Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Feb;96(2):314-21.
doi: 10.1046/j.1365-2567.1999.00682.x.

Characterization of immune responses following intramuscular DNA immunization with the MOMP gene of Chlamydia trachomatis mouse pneumonitis strain

Affiliations

Characterization of immune responses following intramuscular DNA immunization with the MOMP gene of Chlamydia trachomatis mouse pneumonitis strain

D J Zhang et al. Immunology. 1999 Feb.

Abstract

Studies were carried out to characterize the cellular and humoral immune responses evoked by intramuscular DNA vaccination with the major outer membrane protein (MOMP) gene of Chlamydia trachomatis mouse pneumonitis strain. The data demonstrate that DNA vaccinated mice develop antigen-specific delayed-type hypersensitivity, lymphocyte proliferation and interferon-gamma (IFN-gamma) production. Serum antibody responses (mainly immunoglobulin G2a; IgG2a) were evoked in two-thirds of the mice. We conclude that intramuscular DNA immunization with the MOMP gene evokes cellular and humoral immune responses suggestive of a T helper 1 (Th1) bias.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Protective immunity elicited by MOMP DNA (pMOMP) vaccination. BALB/c mice (4–5/group) were immunized with different amounts of the pMOMP DNA intramuscularly on four occasions at 0, 3, 6, 8 weeks. 100 μg of vector DNA (pcDNA3) was injected intramuscularly as a negative control on the same occasions. The mice were challenged with 5×103 IFU of MoPn EB intranasally and killed on the 10th day postinfection. The MoPn growth in the lung was analysed by quantitative tissue culture. The data represents mean +SEM of the log10 IFU per lung. *P < 0·05 when compared with pcDNA3 treated group.
Figure 2
Figure 2
(a) The DTH reaction in mice elicited by immunization by MOMP DNA immunization. BALB/c mice (four/group) were immunized by 200 μg of MOMP DNA (pMOMP) or vector DNA (– pcDNA3) in both quadriceps muscles (100 μg DNA/100 μl/injection site) on four occasions at 0, 3, 6, 8 weeks. A group of mice were also immunized intramuscularly with 5×106 IFUs of UV-inactivated MoPn EBs on the same time schedule. DTH was evaluated 2 weeks after last immunization. UV-killed MoPn EB (25 μl; 2×105 IFU) in SPG buffer was injected into a hind footpad. SPG buffer (25 μl) was injected into the other hind footpads as control. Footpad swelling was measured at 48 hr and 72 hr following the injection. The difference in thickness between the two footpads was used as a measure of the DTH. (b) Lymphocyte proliferation of the mice immunized with pMOMP. BALB/c mice (four to six/group) were immunized with pMOMP, pcDNA3 or MoPn EBs as described in (a). Mice were killed 2 weeks after the last immunization. 5×105 cells/well of spleen cells in 200 μl of RPMI-1640 medium containing 10% FCS and 5×10−5 M 2ME were incubated with 1×105 IFU of UV killed MoPn in 5% CO2 at 37° for 96 hr. Negative control wells contained spleen cells without EB. 3H-Thymidine (0·25 μCi) was added 16 hr before harvest. The cells were harvested after incubation for 96 hr and 3H-thymidine uptake was counted in scintillation solution using a Beckman LS5000 B-counter. *P < 0·05, **P < 0·01, when compared with the pcDNA group.
Figure 3
Figure 3
Profile of IFN-γ and IL-10 production by spleen cells isolated from pMOMP-immunized mice. Mice (four to six) were immunized by pMOMP, pcDNA3 or MoPn EB as described in Fig. 2. Spleen cells were collected two weeks after the last immunization. Spleen cells (5×106 cells/ml) were incubated with 2×105 IFU of UV-killed MoPn EB for 96 hr. The amount of IFN-γ (a) and IL-10 (c) in the supernatant of the cell culture was measured by ELISA. The number of IFN-γ- (b) and IL-10- (d) producing cells per 2×105 spleen cells was tested by ELISPOT. *P < 0·05, **P < 0·01, when compared with pcDNA3-immunized control group.
Figure 4
Figure 4
The profile of IgG subclass of MoPn-specific Ab responses in serum of mice immunized with pMOMP. Balb/c mice were immunized by pMOMP or pcDNA3 or MoPn EB as described in Fig. 2. Sera were collected from the immunized mice 2 weeks after last immunization. MoPn-specific IgG1 and IgG2a Abs were tested by ELISA. The cutoff point was 0·5 on OD 405 nm.
Figure 5
Figure 5
Detection of serum antibody against MoPn MOMP in pMOMP immunized mice by immunoblot. Balb/c mice were immunized with pMOMP (lane 1–12), or pcDNA3 (lane pc1 and pc2) or MoPn EB (lane EB) as described in Fig. 1(a). Lane N is the serum collected from a nonimmunized mouse. Sera collected from immunized mice at two weeks post last immunization were diluted at 1:100 and reacted with purified MoPn MOMP protein that had been separated in 10% SDS–polyacrylamide gel and transferred to a nitrocellulose membrane. The bands were developed by the ECL method.

Similar articles

Cited by

References

    1. Brunham RC. Vaccine design for the prevention of Chlamydia trachomatis infection. In: Orfila J, Byme G I, Chernesky M A, editors. Chlamydial Infections Proceedings of the Eighth International Symposium on Human Chlamydial Infections (Chantilly, France) Bologna, Italy: Società Editrice Esculapio; 1994. p. 73.
    1. Brunham RC, Peeling RW. Chlamydia trachomatis antigens: role in immunity and pathogenesis. Infectious Agents and Disease. 1994;3:218. - PubMed
    1. Stephens RS. Challenge of Chlamydia research. Infectious Agents and Disease. 1993;1:279. - PubMed
    1. Brunham RC, Kimani J, Bwayo J, et al. The epidemiology of Chlamydia trachomatis within a sexually transmitted diseases core group. J Infect Dis. 1996;173:950. - PubMed
    1. Jawetz E, Rose L, Hanna L, Thygeson P. Experimental inclusion conjunctivitis in man. JAMA. 1965;194:620. - PubMed

Publication types